Nicholas Blondin, MD
Associate ProfessorCards
About
Research
Academic Achievements & Community Involvement
Clinical Care
Overview
Nicholas A. Blondin, MD, is a Yale Medicine neurologist who specializes in treating benign (noncancerous) and malignant (cancerous) brain tumors, brain and spine metastasis, and neurological symptoms of cancer such as seizures, cognitive impairment, headaches, gait disturbance, and weakness. He cares for patients at Smilow Cancer Hospital in New Haven and the Smilow Cancer Hospital Cancer Care Center in Trumbull.
“I love developing a strong doctor-patient relationship with my patients,” Dr. Blondin says. “I believe that a strong, trusting relationship is critical for me to help patients achieve their treatment goals and have the best possible quality of life.”
Dr. Blondin believes in “shared decision making,” a process he uses to create a treatment plan that will be best for each patient. “With a difficult diagnosis, I am open and honest but also work to provide hope that treatment will be effective,” Dr. Blondin says. “I let patients know that I will always be there for them, and I will support them in all phases of treatment.”
Together with a team of doctors at Smilow, he is able to help more patients achieve better outcomes. “In neuro-oncology, I rely on additional specialists such as neurosurgeons, radiation oncologists, pathologist, and neuro-radiologists in order to provide the best care for my patients,” he says.
Dr. Blondin is an active investigator for clinical trials for brain tumor patients through Yale Cancer Center and is an assistant professor of clinical neurology at Yale School of Medicine.
Clinical Specialties
Fact Sheets
Brain Tumors
Learn More on Yale MedicineAtypical Teratoid/Rhabdoid Tumors
Learn More on Yale MedicineGuillain-Barré Syndrome
Learn More on Yale MedicineNeuroblastoma
Learn More on Yale Medicine
Board Certifications
Neuro-Oncology
- Certification Organization
- United Council for Neurologic Subspecialties
- Latest Certification Date
- 2022
- Original Certification Date
- 2015